These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Socioeconomic and racial disparities of pediatric invasive pneumococcal disease after the introduction of the 7-valent pneumococcal conjugate vaccine. Spicer JO; Thomas S; Holst A; Baughman W; Farley MM Pediatr Infect Dis J; 2014 Feb; 33(2):158-64. PubMed ID: 24418837 [TBL] [Abstract][Full Text] [Related]
4. Epidemiologic relation between HIV and invasive pneumococcal disease in San Francisco County, California. Nuorti JP; Butler JC; Gelling L; Kool JL; Reingold AL; Vugia DJ Ann Intern Med; 2000 Feb; 132(3):182-90. PubMed ID: 10651598 [TBL] [Abstract][Full Text] [Related]
5. Declining incidence of invasive Streptococcus pneumoniae infections among persons with AIDS in an era of highly active antiretroviral therapy, 1995-2000. Heffernan RT; Barrett NL; Gallagher KM; Hadler JL; Harrison LH; Reingold AL; Khoshnood K; Holford TR; Schuchat A J Infect Dis; 2005 Jun; 191(12):2038-45. PubMed ID: 15897989 [TBL] [Abstract][Full Text] [Related]
6. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era. Robinson KA; Baughman W; Rothrock G; Barrett NL; Pass M; Lexau C; Damaske B; Stefonek K; Barnes B; Patterson J; Zell ER; Schuchat A; Whitney CG; JAMA; 2001 Apr; 285(13):1729-35. PubMed ID: 11277827 [TBL] [Abstract][Full Text] [Related]
7. Population-based surveillance for childhood invasive pneumococcal disease in the era of conjugate vaccine. Hsu K; Pelton S; Karumuri S; Heisey-Grove D; Klein J; Pediatr Infect Dis J; 2005 Jan; 24(1):17-23. PubMed ID: 15665705 [TBL] [Abstract][Full Text] [Related]
8. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. Hofmann J; Cetron MS; Farley MM; Baughman WS; Facklam RR; Elliott JA; Deaver KA; Breiman RF N Engl J Med; 1995 Aug; 333(8):481-6. PubMed ID: 7623880 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients. Breiman RF; Keller DW; Phelan MA; Sniadack DH; Stephens DS; Rimland D; Farley MM; Schuchat A; Reingold AL Arch Intern Med; 2000 Sep; 160(17):2633-8. PubMed ID: 10999977 [TBL] [Abstract][Full Text] [Related]
11. Bacteremia with Streptococcus pneumoniae. Implications for therapy and prevention. Franklin County Pneumonia Study Group. Plouffe JF; Breiman RF; Facklam RR JAMA; 1996 Jan; 275(3):194-8. PubMed ID: 8604171 [TBL] [Abstract][Full Text] [Related]
12. Pneumococcal vaccination in nursing homes: does race make a difference? Marsteller JA; Tiggle RB; Remsburg RE; Bardenheier B; Shefer A; Han B J Am Med Dir Assoc; 2008 Nov; 9(9):641-7. PubMed ID: 18992696 [TBL] [Abstract][Full Text] [Related]
13. The status of invasive pneumococcal disease among children younger than 5 years of age in north-west Lombardy, Italy. Riva E; Salvini F; Garlaschi ML; Radaelli G; Giovannini M BMC Infect Dis; 2012 May; 12():106. PubMed ID: 22554011 [TBL] [Abstract][Full Text] [Related]
14. Herd immunity and pneumococcal conjugate vaccine: a quantitative model. Haber M; Barskey A; Baughman W; Barker L; Whitney CG; Shaw KM; Orenstein W; Stephens DS Vaccine; 2007 Jul; 25(29):5390-8. PubMed ID: 17583392 [TBL] [Abstract][Full Text] [Related]
15. Pneumococcal bacteremia in Monroe County, New York. Bennett NM; Buffington J; LaForce FM Am J Public Health; 1992 Nov; 82(11):1513-6. PubMed ID: 1443302 [TBL] [Abstract][Full Text] [Related]
16. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study. Waight PA; Andrews NJ; Ladhani SN; Sheppard CL; Slack MP; Miller E Lancet Infect Dis; 2015 May; 15(5):535-43. PubMed ID: 25801458 [TBL] [Abstract][Full Text] [Related]
17. A surveillance system of Invasive Pneumococcal Disease in North-Eastern Italy. Baldovin T; Lazzari R; Russo F; Bertoncello C; Buja A; Furlan P; Cocchio S; Palù G; Baldo V Ann Ig; 2016; 28(1):15-24. PubMed ID: 26980506 [TBL] [Abstract][Full Text] [Related]
18. Invasive Pneumococcal Disease Following the Introduction of 13-Valent Conjugate Vaccine in Children in New York City From 2007 to 2012. Farnham AC; Zimmerman CM; Papadouka V; Konty KJ; Zucker JR; Nattanmai GV; Jose S; Rosen JB JAMA Pediatr; 2015 Jul; 169(7):646-52. PubMed ID: 25938798 [TBL] [Abstract][Full Text] [Related]
19. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. Lexau CA; Lynfield R; Danila R; Pilishvili T; Facklam R; Farley MM; Harrison LH; Schaffner W; Reingold A; Bennett NM; Hadler J; Cieslak PR; Whitney CG; JAMA; 2005 Oct; 294(16):2043-51. PubMed ID: 16249418 [TBL] [Abstract][Full Text] [Related]
20. Recurrent invasive pneumococcal disease in children--host factors and vaccination response. Ingels HA Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183055 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]